First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement
(NASDAQ: ANAB) Delayed: 59.43 -0.56 (0.93%)
Previous Close $59.99    52 Week High $ 
Open $59.23    52 Week Low $ 
Day High $62.32    P/E N/A 
Day Low $58.88    EPS $ 
Volume 405,993